Advocate Lutheran General Cancer Care Center
Park Ridge, Illinois, United States
Oncologist in Park Ridge, Illinois
1st & 2nd Floors, 1700 Luther Ln, Park Ridge, IL 60068
About Advocate Lutheran General Cancer Care Center
"Learn more about the Advocate Lutheran General Cancer Institute."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Advocate Lutheran General Cancer Care Center
During the past decade, Advocate Lutheran General Cancer Care Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 15 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
2009-03-25
2012-10-18
Terminated
105
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
2012-10-24
2018-09-06
Completed
583
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Advocate Lutheran General Cancer Care Center" #1 sponsor was "Children's Oncology Group" with 12 trials, followed by "NSABP Foundation Inc" with 6 trials
sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "Dendreon" with 2 trials sponsored and "Northwestern University"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Advocate Lutheran General Cancer Care Center"
#1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Advocate Lutheran General Cancer Care Center
According to Clinical.Site data, the most researched conditions in "Advocate Lutheran General Cancer Care Center" are
"Breast Cancer" (7 trials), "Brain Tumor" (3 trials), "Central Nervous System Tumors" (3 trials), "Leukemia" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Advocate Lutheran General Cancer Care Center" in a lesser frequency.
Clinical Trials Intervention Types at Advocate Lutheran General Cancer Care Center
Most popular intervention types in "Advocate Lutheran General Cancer Care Center" are "Drug" (24 trials), "Radiation" (12 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (8 trials), "etoposide" (6 trials), "radiation therapy" (6 trials), "carboplatin" (5 trials) and "vincristine sulfate" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Advocate Lutheran General Cancer Care Center
The vast majority of trials in "Advocate Lutheran General Cancer Care Center" are
22 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Advocate Lutheran General Cancer Care Center
Currently, there are NaN active trials in "Advocate Lutheran General Cancer Care Center".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Advocate Lutheran General Cancer Care Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Advocate Lutheran General Cancer Care Center, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".